Audard, Vincent <br/><br/>
Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation.  [electronic resource] 

 -  Transplant international : official journal of the European Society for Organ Transplantation  May 2012 
 - e62-6 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1432-2277 
<br/><br/><label>Standard No.: </label>10.1111/j.1432-2277.2012.01462.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Child<br/>Female<br/>Glomerulosclerosis, Focal Segmental--prevention & control<br/>Humans<br/>Kidney Transplantation--adverse effects<br/>Male<br/>Plasmapheresis<br/>Recurrence<br/>Reoperation<br/>Retrospective Studies<br/>Risk Factors<br/>Rituximab<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult